Pancreatic Cancer Research

ResearcherKumamoto UniversityActive in the last 2 years

Chuan Lan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6101-222X; OpenAlex author ID A5052033113. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 9

  1. High SOX17 expression is correlated with favorable prognosis and CD8(+) TILs expression in patients with pancreatic cancer after curative resection. Last author DOI 10.1016/j.tranon.2026.102859↗
  2. Prognostic Value of TBC1D1 and Its Relationship With the Tumor Microenvironment in Pancreatic Cancer: A Study Based on Single-Cell Sequencing. Co-author DOI 10.1096/fba.2025-00092↗
  3. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Last author DOI 10.3389/fonc.2025.1521616↗
  4. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer. Last author DOI 10.3389/fimmu.2024.1341209↗
  5. The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. Co-author DOI 10.1097/mpa.0000000000002210↗
  6. High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1245/s10434-022-11500-9↗
  7. Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer via the Wnt/β-catenin pathway Co-author DOI 10.21203/rs.3.rs-1976828/v1↗
  8. Comprehensive analysis of prognostic value and immune infiltration of calpains in pancreatic cancer. Co-author DOI 10.21037/jgo-21-705↗
  9. Magnetic resonance imaging for preoperative staging of pancreatic cancer based on the 8th edition of AJCC guidelines. Co-author DOI 10.21037/jgo.2020.03.06↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dawei Deng · 4 shared papers, 2022–2025 · strength 0.80
  2. Jianshui Li · 4 shared papers, 2021–2025 · strength 0.70
  3. Guangnian Zhang · 3 shared papers, 2022–2025 · strength 0.55
  4. Jun Qing Yu · 2 shared papers, 2024–2025 · strength 0.42
  5. Yong Li · 2 shared papers, 2024–2025 · strength 0.42
  6. Yifu Hou · 2 shared papers, 2021–2024 · strength 0.34
  7. Jun Yu · 1 shared paper, 2026 · strength 0.32
  8. Yuehua Chen · 1 shared paper, 2026 · strength 0.32
  9. Hiromitsu Hayashi · 2 shared papers, 2022–2023 · strength 0.31
  10. Kosuke Mima · 2 shared papers, 2022–2023 · strength 0.31
  11. Takayoshi Kaida · 2 shared papers, 2022–2023 · strength 0.31
  12. Katsunori Imai · 2 shared papers, 2022–2023 · strength 0.31
  13. Zhao Liu · 2 shared papers, 2022–2023 · strength 0.31
  14. Shigeki Nakagawa · 2 shared papers, 2022–2023 · strength 0.31
  15. Linfeng Yang · 1 shared paper, 2025 · strength 0.25
  16. Peng Yi · 1 shared paper, 2025 · strength 0.25
  17. Yi Chen · 1 shared paper, 2025 · strength 0.22
  18. Dongmei Ren · 1 shared paper, 2024 · strength 0.20
  19. Masayo Tsukamoto · 1 shared paper, 2023 · strength 0.17
  20. Hideo Baba · 1 shared paper, 2023 · strength 0.17
  21. Hideo Baba · 1 shared paper, 2022 · strength 0.14
  22. Takashi Matsumoto · 1 shared paper, 2022 · strength 0.14
  23. Xiaobin Huang · 1 shared paper, 2022 · strength 0.13
  24. Jun Yu · 1 shared paper, 2022 · strength 0.13
  25. Xingyu Liu · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.